TR200103604T2 - En az bir zaman ayarlı vurum üreten kontrollü salım için farmasötik dozaj formları - Google Patents

En az bir zaman ayarlı vurum üreten kontrollü salım için farmasötik dozaj formları

Info

Publication number
TR200103604T2
TR200103604T2 TR2001/03604T TR200103604T TR200103604T2 TR 200103604 T2 TR200103604 T2 TR 200103604T2 TR 2001/03604 T TR2001/03604 T TR 2001/03604T TR 200103604 T TR200103604 T TR 200103604T TR 200103604 T2 TR200103604 T2 TR 200103604T2
Authority
TR
Turkey
Prior art keywords
dosage forms
pharmaceutical dosage
controlled release
timed pulse
release producing
Prior art date
Application number
TR2001/03604T
Other languages
English (en)
Inventor
Andre Frederic
Lewis Gareth
Mignonneau Jerome
Ribardiere Agnes
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of TR200103604T2 publication Critical patent/TR200103604T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Mevcut bulus, çekirdeklerinde bir aktif madde içeren geciktirilmis salma kapli çekirdekler ve en az bir ya da daha fazla amonyo metakrilat kopolimer içeren bir polimer kaplama ile ilgili olup, bu gibi geciktirilmis salma kapli çekirdekler içeren monolitik ya da çok partikülatli farmasötik dozaj formlara ve bunlarin üretim metoduna en az bir sürfaktanin içerilmesi ile karakterize edilir.
TR2001/03604T 1999-06-28 2000-06-27 En az bir zaman ayarlı vurum üreten kontrollü salım için farmasötik dozaj formları TR200103604T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99401606A EP1064938A1 (en) 1999-06-28 1999-06-28 Pharmaceutical dosage forms for controlled release producing at least a timed pulse

Publications (1)

Publication Number Publication Date
TR200103604T2 true TR200103604T2 (tr) 2002-04-22

Family

ID=8242029

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/03604T TR200103604T2 (tr) 1999-06-28 2000-06-27 En az bir zaman ayarlı vurum üreten kontrollü salım için farmasötik dozaj formları

Country Status (29)

Country Link
US (1) US20080175910A1 (tr)
EP (2) EP1064938A1 (tr)
JP (1) JP2003503341A (tr)
KR (1) KR100794402B1 (tr)
CN (2) CN1358088A (tr)
AR (1) AR024492A1 (tr)
AT (1) ATE274902T1 (tr)
AU (1) AU780769B2 (tr)
BR (1) BR0011999A (tr)
CA (1) CA2370067C (tr)
CO (1) CO5190681A1 (tr)
CZ (1) CZ296067B6 (tr)
DE (1) DE60013445T2 (tr)
DK (1) DK1194131T3 (tr)
ES (1) ES2225183T3 (tr)
HK (1) HK1043056B (tr)
HU (1) HU229312B1 (tr)
IL (2) IL146768A0 (tr)
MX (1) MXPA01013408A (tr)
NO (1) NO332952B1 (tr)
NZ (1) NZ515826A (tr)
PL (1) PL200816B1 (tr)
PT (1) PT1194131E (tr)
SI (1) SI1194131T1 (tr)
SK (1) SK285359B6 (tr)
TR (1) TR200103604T2 (tr)
TW (1) TWI242451B (tr)
WO (1) WO2001000182A1 (tr)
ZA (1) ZA200109849B (tr)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ527832A (en) 2001-03-13 2006-03-31 Penwest Pharmaceuticals Co Chronotherapeutic dosage forms
DE10149674A1 (de) 2001-10-09 2003-04-24 Apogepha Arzneimittel Gmbh Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
JP2005512997A (ja) * 2001-11-07 2005-05-12 シントン・ベスローテン・フェンノートシャップ タムスロシン錠
ATE356625T1 (de) * 2001-11-30 2007-04-15 Pfizer Prod Inc Orale pharmazeutische zusammensetzungen mit verzögerter freisetzung enthaltend 5,8,14- triazatetracyclo (10.3.1.0(2,11) 0 (4,9) )- hexadeca-2(11) 3, 5,7, 9-pentaene
JP4417110B2 (ja) * 2001-12-19 2010-02-17 株式会社三和化学研究所 放出制御型成型品
DE60334378D1 (de) * 2002-07-05 2010-11-11 Temrel Ltd Zusammensetzung zur kontrollierten wirkstoffabgabe
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
EP1556014A1 (en) * 2002-10-22 2005-07-27 Ranbaxy Laboratories, Ltd. Sustained release compositions containing alfuzosin
US7018658B2 (en) * 2002-11-14 2006-03-28 Synthon Bv Pharmaceutical pellets comprising tamsulosin
KR100592512B1 (ko) * 2002-11-22 2006-07-03 서울약품공업(주) 탐술로신 또는 약제학적으로 허용되는 이의 염을활성성분으로 하는 서방성 배뇨장애 치료제
IN192381B (tr) * 2002-12-20 2004-04-10 Ranbaxy Lab
EA200600598A1 (ru) * 2003-09-19 2006-08-25 Пенвест Фармасьютикалз Ко. Лекарственные формы замедленного высвобождения
AU2004273958A1 (en) * 2003-09-19 2005-03-31 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms
GB2407498B (en) * 2003-10-30 2008-06-11 Cipla Ltd Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
KR100436701B1 (ko) * 2003-11-07 2004-06-22 주식회사 씨티씨바이오 염산 탐스로신 함유 방출 조절형 제제 및 그의 제조방법
US8292729B2 (en) 2003-12-02 2012-10-23 United Tote Company Methods and systems for presenting pari-mutuel betting options and constructing wagers
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
AR051654A1 (es) * 2004-11-04 2007-01-31 Astrazeneca Ab Nuevas formulaciones de pellets de liberacion modificada para inhibidores de la bomba de protones
AR052225A1 (es) * 2004-11-04 2007-03-07 Astrazeneca Ab Formulaciones de tabletas de liberacion modificada par inhibidores de la bomba de protones
WO2006055659A2 (en) * 2004-11-15 2006-05-26 Smithkline Beecham Corporation Fixed dose combination op dutasteride and tamsulosin
KR20070087678A (ko) 2004-12-20 2007-08-28 컬리지움 파마슈티칼, 인코포레이티드 수면 장애용 약제 조성물
KR20070102563A (ko) * 2005-01-26 2007-10-18 엘란 파마 인터내셔널 리미티드 정신병치료제를 함유하는 조절방출형 조성물
EP1868580A1 (en) * 2005-03-29 2007-12-26 Evonik Röhm GmbH Multiparticulate pharmaceutical form comprising pellets with a matrix which influences the delivery of a modulatory substance
US8206742B2 (en) 2006-01-12 2012-06-26 Wockhardt Ltd. Sustained release compositions of alfuzosin
US20070292505A1 (en) * 2006-06-15 2007-12-20 Abrika Pharmaceuticals, Inc. Controlled release alfuzosin hydrochloride formulation
US20080095844A1 (en) * 2006-10-23 2008-04-24 Rajhans Sujay Kamalakar Sustained release pharmaceutical compositions of alfuzosin and process for preparation thereof
CN101269056B (zh) * 2007-03-19 2010-05-19 天津药物研究院 一种美托洛尔盐类口服脉冲微丸制剂
US8178483B2 (en) * 2007-03-30 2012-05-15 Colgate-Palmolive Company Polymeric encapsulates having a quaternary ammonium salt and methods for producing the same
JP5228359B2 (ja) * 2007-04-12 2013-07-03 ニプロ株式会社 主薬粒子及びその製造方法ならびに口腔内崩壊錠
FR2928929B1 (fr) * 2008-03-19 2012-01-13 Saint Gobain Composition serigraphiable sur polyvinylbutyral
WO2011049309A2 (ko) 2009-10-09 2011-04-28 영진약품공업 주식회사 속효성과 지속성을 동시에 갖는 약제학적 조성물
CN102106841B (zh) * 2009-12-24 2013-01-09 杭州康恩贝制药有限公司 一种盐酸坦洛新制剂及其制备方法
JO3112B1 (ar) 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
RU2566269C2 (ru) 2010-03-29 2015-10-20 Ферринг Б.В. Быстрорастворимая фармацевтическая композиция
KR101686033B1 (ko) * 2010-04-12 2016-12-13 주식회사 대웅제약 탐술로신 또는 이의 약제학적 허용 가능한 염을 유효성분으로 함유하는 장용성 서방형 펠렛부와 속방부로 이루어진 의약 조성물
US20130064891A1 (en) * 2010-05-21 2013-03-14 Ashok Sahoo Pharmaceutical compositions of nsaid and acid inhibitor
US8623409B1 (en) 2010-10-20 2014-01-07 Tris Pharma Inc. Clonidine formulation
TW201422254A (zh) * 2012-11-21 2014-06-16 Ferring Bv 用於速釋及延釋的組成物
MX391259B (es) 2015-10-14 2025-03-21 X Therma Inc Composiciones y métodos para reducir la formación de cristales de hielo.
CN105362233A (zh) * 2015-12-07 2016-03-02 黑龙江省智诚医药科技有限公司 一种卡托普利缓释微丸及其制备方法
US10849856B2 (en) 2016-10-31 2020-12-01 Neurim Pharmaceuticals Ltd. Melatonin mini-tablets and method of manufacturing the same
JP6830156B2 (ja) 2016-10-31 2021-02-17 ニューリム・ファーマシューティカルズ・リミテッドＮｅｕｒｉｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ． メラトニンミニタブレットおよびその製造方法
US10278930B2 (en) 2017-03-16 2019-05-07 The Procter & Gamble Company Method for relieving sinus congestion
CN107233328A (zh) * 2017-06-13 2017-10-10 江苏黄河药业股份有限公司 卡托普利缓释片剂及其制备方法
CN107362161B (zh) * 2017-08-14 2020-05-29 黄河科技学院 一种复方卡托普利硝苯地平脉冲缓释制剂及其制备方法
TR201721036A2 (tr) * 2017-12-21 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Flurbi̇profeni̇n modi̇fi̇ye salimli formülasyonlari
JP7162330B2 (ja) * 2018-07-11 2022-10-28 株式会社アタゴ 粘度計
CN110075090A (zh) * 2019-05-17 2019-08-02 南京望知星医药科技有限公司 一种用于治疗呼吸疾病的沙丁胺醇胶囊及其制备方法
CN110037994B (zh) * 2019-05-24 2022-04-12 中国药科大学 一种布洛芬速释缓释双层片及其制备方法
US11918689B1 (en) 2020-07-28 2024-03-05 Tris Pharma Inc Liquid clonidine extended release composition

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA822995B (en) * 1981-05-21 1983-12-28 Wyeth John & Brother Ltd Slow release pharmaceutical composition
US4677099A (en) * 1981-09-04 1987-06-30 Yeda Research And Development Co., Ltd. Medical processes employing a novel lipid fraction
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
JPS58116414A (ja) * 1981-12-23 1983-07-11 Yamanouchi Pharmaceut Co Ltd ニカルジピン持続性製剤用球形顆粒およびその製造法
US4614796A (en) * 1983-03-25 1986-09-30 Nippon Shinyaku Co., Ltd. Liposome and method of manufacture therefor
EP0212746B1 (en) * 1985-08-16 1991-04-10 The Procter & Gamble Company Drug particles having constant release
US4986987A (en) * 1986-05-09 1991-01-22 Alza Corporation Pulsed drug delivery
US4994273A (en) * 1987-11-02 1991-02-19 Merck & Co., Inc. Solubility modulated drug delivery device
ES2077023T3 (es) * 1989-03-10 1995-11-16 Yamanouchi Pharma Co Ltd Material de recubrimiento que controla la liberacion de un medicamento para formulaciones de actividad prolongada.
US5176901A (en) * 1991-04-10 1993-01-05 Smithkline Beecham Corporation Dental composition
DE69222006T2 (de) * 1991-10-30 1998-01-22 Glaxo Group Ltd Mehrschichtzusammensetzungen enthaltend Histamin- oder Serotonin- Antagonisten
CZ282760B6 (cs) * 1991-11-22 1997-09-17 Procter And Gamble Pharmaceuticals, Inc. Risedronátové prostředky se zpožděným uvolňováním
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
ES2194863T3 (es) * 1992-11-30 2003-12-01 Kv Pharm Co Materiales farmaceuticos con enmascarado de sabor.
EP0711166A1 (en) * 1993-07-22 1996-05-15 Warner-Lambert Company Controlled release tacrine drug delivery systems and methods for preparing same
FR2717388B1 (fr) * 1994-03-21 1996-11-22 Synthelabo Formes galéniques à libération prolongée du chlorhydrate d'alfuzosine.
US5834024A (en) * 1995-01-05 1998-11-10 Fh Faulding & Co. Limited Controlled absorption diltiazem pharmaceutical formulation
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
IL116674A (en) * 1995-01-09 2003-05-29 Mendell Co Inc Edward Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
IE80467B1 (en) * 1995-07-03 1998-07-29 Elan Corp Plc Controlled release formulations for poorly soluble drugs
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
DE19637082A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Schnellzerfallende Pellets
US6020375A (en) * 1997-06-13 2000-02-01 Senju Pharmaceutical Co., Ltd. Bactericidal composition
BR9802915A (pt) * 1997-09-12 2000-01-11 Oscar Gold Procedimento para formar composições farmaceuticas em pilulas ou granulos substancialmente esfericos, de ação controlada e continuada, contendo como agente ativo o (7-bromo-1,3-diidro-5-(2-piridninilo)-2h-1,4-benzodiazep ina-2(1h)-um)
US6066339A (en) * 1997-10-17 2000-05-23 Elan Corporation, Plc Oral morphine multiparticulate formulation
US5922341A (en) * 1997-10-28 1999-07-13 Vivus, Incorporated Local administration of pharmacologically active agents to treat premature ejaculation
DK173431B1 (da) * 1998-03-20 2000-10-23 Gea Farmaceutisk Fabrik As Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs
US6124362A (en) * 1998-07-17 2000-09-26 The Procter & Gamble Company Method for regulating hair growth
US6270805B1 (en) * 1998-11-06 2001-08-07 Andrx Pharmaceuticals, Inc. Two pellet controlled release formulation for water soluble drugs which contains an alkaline metal stearate
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6495498B2 (en) * 1999-05-27 2002-12-17 Johnson & Johnson Consumer Companies, Inc. Detergent compositions with enhanced depositing, conditioning and softness capabilities
EP1064937A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof

Also Published As

Publication number Publication date
PL354399A1 (en) 2004-01-12
CA2370067A1 (en) 2001-01-04
DE60013445T2 (de) 2005-09-01
DE60013445D1 (de) 2004-10-07
IL146768A (en) 2010-05-17
WO2001000182A1 (en) 2001-01-04
CN101669914A (zh) 2010-03-17
AU780769B2 (en) 2005-04-14
CN1358088A (zh) 2002-07-10
PT1194131E (pt) 2005-01-31
CZ20014639A3 (cs) 2002-04-17
ES2225183T3 (es) 2005-03-16
NZ515826A (en) 2004-04-30
US20080175910A1 (en) 2008-07-24
HUP0202259A3 (en) 2004-05-28
HK1043056B (en) 2005-04-29
PL200816B1 (pl) 2009-02-27
SK19102001A3 (sk) 2002-05-09
EP1194131B1 (en) 2004-09-01
CA2370067C (en) 2009-07-28
ATE274902T1 (de) 2004-09-15
MXPA01013408A (es) 2002-07-30
HU229312B1 (hu) 2013-10-28
SK285359B6 (sk) 2006-11-03
SI1194131T1 (en) 2005-04-30
NO332952B1 (no) 2013-02-11
KR100794402B1 (ko) 2008-01-16
CO5190681A1 (es) 2002-08-29
EP1194131A1 (en) 2002-04-10
TWI242451B (en) 2005-11-01
HK1043056A1 (en) 2002-09-06
ZA200109849B (en) 2003-02-26
DK1194131T3 (da) 2005-01-17
AU6274700A (en) 2001-01-31
CZ296067B6 (cs) 2006-01-11
BR0011999A (pt) 2002-03-05
AR024492A1 (es) 2002-10-02
KR20020015065A (ko) 2002-02-27
HUP0202259A2 (hu) 2002-12-28
JP2003503341A (ja) 2003-01-28
NO20016282L (no) 2002-02-27
IL146768A0 (en) 2002-07-25
NO20016282D0 (no) 2001-12-20
EP1064938A1 (en) 2001-01-03

Similar Documents

Publication Publication Date Title
TR200103604T2 (tr) En az bir zaman ayarlı vurum üreten kontrollü salım için farmasötik dozaj formları
TR200002130T2 (tr) Sferoitler, hazırlama yöntemi ve farmasötik bileşimler.
BR0207932A (pt) Composições farmacêuticas de sabor mascarado
SE9704870D0 (sv) New pharmaceutical formulation I
DE59911452D1 (de) Überzogene arzneiformen mit kontrollierter wirkstoffabgabe
MA25811A1 (fr) Systeme de diffusion d'une fragrance a duree amelioree; procurant une sensation premiere de fragrance non-alteree.
TR199700948T1 (tr) Antoganoistik aktiviteye sahip 1,4-piperidin esterleri ve amidleri.
ATE361061T1 (de) Beschichtungszusammensetzung zur geschmacksmaskierung
ATE429907T1 (de) Zusammensetzungen mit verzögerter freigabe enthaltend venlafaxinhydrochlorid als wirkstoff
NO20004859L (no) Transdermale, terapeutiske systemer (TTS) inneholdende pergolid
DE60330144D1 (de) Beschichtung von stents mit verzögerter wirkstofffreisetzung
TNSN00010A1 (fr) DIPHENYLUREE A SUBSTITUTION ω CARBOXYARYLE SERVANT D'INHIBUTEURS DE RAF KINASE.
TR200201028T2 (tr) Tablet özlerinin kaplanması
BR0012046A (pt) Composto heterocìclico, composição farmacêutica, inibidor de ativação de ap-1 ou um inibidor da ativação de nf-kappab, inibidor da produção de citocina inflamatória, e, inibidor da produção de metaloprotease de matriz ou inibidor da expressão do fator de adesão de célula inflamatória
TR200201638T2 (tr) Yeni imidazo[1,3,5]triazinonlar ve kullanımları
ATE260658T1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
DK0948320T3 (da) Lægemidler til forhalet frigivelse af HMG-CoA-reduktaseinhibitoren fluvastatin
DK0994696T3 (da) Farmaceutisk præparat til kontrolleret frigörelse med indhold af ACE-hæmmer som aktivt stof
DE69616074D1 (de) Ara-c derivate
DE60028730D1 (de) Multipartikuläre bisoprolol formulierung
MXPA04003540A (es) Utilizacion de un copolimero para producir una forma galenica que contiene un peptido o proteina como agente activo.
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
ATE239469T1 (de) Alpha-liponsäure(-derivate)enthaltende retardform
EP1352657A4 (en) THERAPEUTIC AGENTS THAT ENHANCE THE EFFECT OF INTERFERON
ATE380018T1 (de) Verfahren zur herstellung von wirkstoffhaltigen pellets